Detalles de la búsqueda
1.
Second-line lenvatinib in patients with recurrent endometrial cancer.
Gynecol Oncol
; 156(3): 575-582, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31955859
2.
A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer.
Gynecol Oncol
; 156(1): 23-31, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31791552
3.
Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer.
Gynecol Oncol
; 123(3): 479-85, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21978765
4.
A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive Relapse.
J Clin Oncol
; 34(19): 2271-8, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27001568
5.
PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.
J Clin Oncol
; 31(35): 4400-6, 2013 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24127448
6.
OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
J Clin Oncol
; 30(17): 2039-45, 2012 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22529265
7.
Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer.
J Clin Oncol
; 27(9): 1426-31, 2009 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19224848
8.
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.
J Clin Oncol
; 25(19): 2811-8, 2007 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17602086
9.
Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancer.
Gynecol Oncol
; 85(1): 129-35, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11925132
Resultados
1 -
9
de 9
1
Próxima >
>>